Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
Cancers · 27.10.2023 · 15 (21) · 5178
DOI: 10.3390/cancers15215178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.10.2023. Verfasst von Mario Romeo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hepatogastroenterology Division, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138 Naples, Italy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a predominant malignancy with increasing incidences and mortalities worldwide. In Western countries, the progressive affirmation of Non-alcoholic Fatty Liver Disease (NAFLD) as the main chronic liver disorder in which HCC occurrence is appreciable even in non-cirrhotic stages, constitutes a real health emergency. In light of this, a further comprehension of molecular pathways supporting HCC onset and progression represents a current research challenge to achieve more tailored prognostic models and appropriate therapeutic approaches. RNA non-coding transcripts (ncRNAs) are involved in the regulation of several cancer-related processes, including HCC. When dysregulated, these molecules, conventionally classified as “small ncRNAs” (sncRNAs) and “long ncRNAs” (lncRNAs) have been reported to markedly influence HCC-related progression mechanisms. In this review, we describe the main dysregulated ncRNAs and the relative molecular pathways involved in HCC progression, analyzing their implications in certain etiologically related contexts, and their applicability in clinical practice as novel diagnostic, prognostic, and therapeutic tools. Finally, given the growing evidence supporting the immune system response, the oxidative stress-regulated mechanisms, and the gut microbiota composition as relevant emerging elements mutually influencing liver-cancerogenesis processes, we investigate the relationship of ncRNAs with this triad, shedding light on novel pathogenetic frontiers of HCC progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatogastroenterology Division, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138 Naples, Italy.
- Biochemistry Division, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138 Naples, Italy.
- Division of Medical Oncology, AORN Azienda dei Colli, Monaldi Hospital, Via Leonardo Bianchi, 80131 Naples, Italy.
ORCID-Profile: Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Annachiara Coppola, Alessandro Federico
Zitieren
APA
Romeo, M., Dallio, M., Scognamiglio, F., Ventriglia, L., Cipullo, M., Coppola, A., Tammaro, C., Scafuro, G., Iodice, P., & Federico, A. (2023). Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers, 15(21), 5178. https://doi.org/10.3390/cancers15215178
Vancouver
Romeo M, Dallio M, Scognamiglio F, Ventriglia L, Cipullo M, Coppola A, et al. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers. 2023;15(21):5178. doi:10.3390/cancers15215178
BibTeX
@article{Romeo2023,
author = {Romeo, Mario and Dallio, Marcello and Scognamiglio, Flavia and Ventriglia, Lorenzo and Cipullo, Marina and Coppola, Annachiara and Tammaro, Chiara and Scafuro, Giuseppe and Iodice, Patrizia and Federico, Alessandro},
title = {Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications},
journal = {Cancers},
year = {2023},
volume = {15},
number = {21},
pages = {5178},
doi = {10.3390/cancers15215178}
}
EUVIMED